novartis_window

Novartis nets first acute myeloid leukaemia approval in Canada, but NICE says no

December 6, 2017
Research and Development, Sales and Marketing Canada, NICE, Novartis, Rydapt, UK, acute myeloid leukaemia, leukaemia, pharma

Novartis is celebrating the news that its drug Rydapt (midostaurin) has been awarded marketing approval in Canada for the treatment …

aaeaaqaaaaaaaadzaaaajda2mmvkoduzltaxndctngywns1iztq3lwm3mtg3mzk0njnkyw

Veeva launches upgrade to Veeva CRM Engage

December 6, 2017
Medical Communications Zinc systems, biotech, drugs, pharma, pharmaceutical, veeva

Veeva took the opportunity at its European Commercial & Medical Summit to reveal the latest upgrade to its Veeva CRM …

diabetes-2424105_960_720

Study reveals diet able to reverse diabetes in half of patients

December 6, 2017
Research and Development biotech, diabetes, drugs, pharma, pharmaceutical

Building on their previous research emerging from Professor Roy Taylor’s work at Newcastle University, a study has found that 45.6% …

novo_flag

Novo Nordisk unveils hard-hitting data for two of its diabetes therapies

December 5, 2017
Manufacturing and Production, Research and Development Novo Nordisk, Tresiba, Xultophy, diabetes, pharma

Novo Nordisk has lifted the curtain on new data from two of its therapies for diabetes, Xultophy (insulin degludec/liraglutide) and …

vanilla-flower-542019_960_720

Vanilla compound found to prevent psoriasis

December 5, 2017
Manufacturing and Production, Research and Development biotech, drugs, pharma, pharmaceutical, psoriasis, vanilla

Psoriasis is a big pharmaceutical market, it’s the most common autoimmune disease in the US and as many as 7.5 …

nhs_sign

NHS talking therapies for mental health hit a high with 1.4 million referrals

December 5, 2017
Manufacturing and Production, Medical Communications NHS, anxiety, depression, mental illness, pharma

New data has revealed that the number of UK patients seeking talking therapies on the NHS is on the rise, …

AbbVie posts strong psoriasis data but can it stand out from crowd?

December 5, 2017
Manufacturing and Production, Research and Development AbbVie, biotech, drugs, pharma, pharmaceutical

AbbVie revealed that its IL-23 inhibitor, risankizumab, had successfully met all of its endpoints in a Phase 3 trials into …

pcpharma_linkedin_banner

ProcureCon Pharma 2018

December 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ProcureCon, biotech, drugs, pharma, pharmaceutical

We are proud to be partnering with the ProcureCon Pharma 2018, the only event in Europe for senior pharma procurement …

Mundipharma names Philippe Mazas as new Chief Information Officer

December 4, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, Philippe Mazas

Mundipharma has announced that it has appointed Philippe Mazas as its new Chief Information Officer (CIO). Mazas boasts nearly 20 …

Akili’s video game digital treatment shows promise in ADHD, eyes FDA approval

December 4, 2017
Research and Development, Sales and Marketing ADHD, AKL-T01, Akili, FDA, pharma, video game

Akili, an unlisted affiliate of London-listed PureTech Health, has unveiled top-line results of AKL-T01, a novel digital medicine which takes …

vaccination-2722937_960_720

The race to find an effective dengue vaccine

December 4, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, biotech, dengue, drugs, pharma, pharmaceutical

Derek Wallace, Global Dengue Program Head at Takeda Vaccine Business Unit, discusses the recent Phase 2 results showing its vaccine …

Recipharm commences new supply contract and completes purchase of facility in Spain

December 4, 2017
Manufacturing and Production Recipharm

Recipharm AB announces that it has today commenced the supply of commercial products to Roche and completed the acquisition of …

yemen-649026_960_720

WHO warns of worst cholera outbreak in modern history in war-torn Yemen

December 4, 2017
Sales and Marketing Cholera, Saudi Arabia, WHO, Yemen, pharma

The conflict and poor economic situation in Yemen is creating a “perfect mix” for a resurgence of cholera in the …

mosquito

Philippines to investigate “shameless public health scam”

December 4, 2017
Sales and Marketing Sanofi, biotech, dengvaxia, drugs, pharma, pharmaceutical

The Philippines has announced that it will investigate how more than 730,000 children received a dengue vaccine, despite safety concerns …

fdaoutsideweb

Mylan’s Ogivri becomes first and only FDA-approved Herceptin biosimilar

December 4, 2017
Sales and Marketing Biocon, Cancer, FDA, Herceptin, Mylan, Roche, biosimilar, pharma

The FDA has announced the approval of Mylan’s Ogivri (trastuzumab-dkst), the first biosimilar version of Roche’s Herceptin to be authorised …

J&J opts in on Idorsia’s candidate for $230m

December 4, 2017
Sales and Marketing Idorsia, Johnson & Johnson, biotech, drugs, pharma, pharmaceutical

As part of Johnson & Johnson’s acquisition of Actelion, it was able to secure a number of ties with the …

busch

Pharma carousel sees Bayer discovery chief head to Shire

December 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Shire, biotech, drugs, pharma, pharmaceutical

It’s no secret that when individuals leave companies within the pharma industry, they tend to pop up at a rival …

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

December 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

We’re officially into December and only one month away from the end of the year. Among our top news this …

fda_building_web

Gottlieb looking to approve cancer treatments on earlier evidence

December 1, 2017
Medical Communications FDA, Scott Gottlieb, biotech, drugs, pharma, pharmaceutical

Scott Gottlieb, FDA commissioner, was speaking in front of the House Committee on Energy and Commerce, regarding the 21st Century …

opioid_crisis

FDA approves first and only therapy of its kind for opioid addiction

December 1, 2017
Medical Communications, Sales and Marketing FDA, Invidior, Sublocade, US, opioid crisis, opioids, pharma

Image Credit:  Marco VerchAs the US languishes in the midst of an opioid crisis which President Trump declared national emergency …

The Gateway to Local Adoption Series

Latest content